Lv41
430 积分 2024-12-16 加入
Goserelin versus leuprolide in the chemical castration of patients with prostate cancer
3小时前
待确认
The pharmacokinetics and pharmacodynamics of a new sustained-release leuprolide acetate depot compared to market references
13天前
已完结
Antiandrogens in Prostate Cancer
21天前
已完结
'Acute on chronic' effect of depot leuprolide in patients with stage D2 cancer of prostate
28天前
已完结
IL-17A, IL-22, and IL-23 as Markers of Psoriasis Activity
2个月前
已完结
An Innovative Approach to Optimize First‐In‐Human Minimal Anticipated Biological Effect Level Based Starting Dose in Oncology Trials for Bispecific T‐Cell Engagers: Experience from A Solid Tumor Bispecific T‐Cell Engager
2个月前
已完结
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
2个月前
已完结
First‐in‐Human Dose Selection for T‐Cell Engaging Bispecific Antibodies
2个月前
已完结
An Integrated Multiple-Analyte Pharmacokinetic Model to Characterize Trastuzumab Emtansine (T-DM1) Clearance Pathways and to Evaluate Reduced Pharmacokinetic Sampling in Patients with HER2-Positive Metastatic Breast Cancer
2个月前
已完结
Clinical Implications of Pathophysiological and Demographic Covariates on the Population Pharmacokinetics of Trastuzumab Emtansine, a HER2‐Targeted Antibody‐Drug Conjugate, in Patients With HER2‐Positive Metastatic Breast Cancer
2个月前
已完结
皖公网安备34019202002308
